
Revenue of BioNTech 2017-2021
In 2021, the annual revenue of biotech company BioNTech SE was nearly 19 billion euros, compared to around 482 million euros in the year before. This statistic illustrates the annual revenue of BioNTech SE worldwide from 2017 to 2021. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.